Charles Explorer logo
🇬🇧

Intravenous immunoglobulins as drug delivery system for target anticancer combined therapy.

Publication

Abstract

Imunotherapy can be induces statistically significant inhibition of tumor growth,invasiveness, angiogenesis and prolongation of survival time. Its combination with anticancer destructing therapies (chemotherapy and photodynamic therapy) can be effective way for tumor destruction without next cancer recurrence.

Therefore, we designed supramolecular multimodal system based on intravenous immunoglobulins for target transport of anticancer drugs and combined therapy. Their study in mice model showed its excellent anticancer affectivity.